Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Non-infectious skin conditions are more common than infectious ones in Kashmir, but community areas see more infections, suggesting a need for better skin care services in primary health care.

COVID-19 can cause or worsen skin issues.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.